---
title: "Plus Therapeutics Sets 2026 Virtual Annual Stockholder Meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278945674.md"
description: "Plus Therapeutics Sets 2026 Virtual Annual Stockholder Meeting"
datetime: "2026-03-12T21:15:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278945674.md)
  - [en](https://longbridge.com/en/news/278945674.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278945674.md)
---

# Plus Therapeutics Sets 2026 Virtual Annual Stockholder Meeting

Plus Therapeutics Sets 2026 Virtual Annual Stockholder Meeting

### Related Stocks

- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [PSTV.US](https://longbridge.com/en/quote/PSTV.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year | CSTL Stock News](https://longbridge.com/en/news/282333053.md)
- [Arcutis Biotherapeutics Targets ZORYVE Expansion, Raises 2026 Outlook and Turns Cash-Flow Positive](https://longbridge.com/en/news/282775123.md)
- [PolyPid To Present New Phase 3 SHIELD II Data On D-PLEX100 At ESCMID 2026](https://longbridge.com/en/news/282665678.md)
- [AbbVie (NYSE:ABBV) Issues Q1 2026 Earnings Guidance](https://longbridge.com/en/news/282227475.md)
- [BioNTech Reports Phase 1/2a Study Data For BNT323/DB-1303 In HER2-Expressing Endometrial Cancer](https://longbridge.com/en/news/282508084.md)